Wednesday, October 14, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document

AI Is Insatiable

View original at spectrum.ieee.org
IEEE Spectrum - Technical Title: AI Is Insatiable Date: 2026-04-06 14:22 Source: https://spectrum.ieee.org/high-bandwidth-memory-shortage <img src="https://spectrum.ieee.org/media-library/robot-hand-catching-falling-computer-chips-from-an-open-snack-bag-in-pop-art-style.png?id=65425799&width=1200&height=800&coordinates…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Generative AI queries consumed 15 terawatt-hours in 2025 and are projected to consume 347 TWh by 2030

    60% confidence
  • If any of the big three HBM companies—Micron, Samsung, and SK Hynix—say that they are adjusting the schedule of the arrival of new production, that'd be an important signal

    60% confidence
  • Startups developing all sorts of products might pivot toward creative redesigns that use less memory

    60% confidence
  • Water consumption for cooling AI data centers is predicted to double or even quadruple by 2028 compared to 2023

    60% confidence
  • If any of the big three HBM companies—Micron, Samsung, and SK Hynix—say that they are adjusting the schedule of the arrival of new production, that'd be an important signal

    60% confidence
  • Water consumption for cooling AI data centers is predicted to double or even quadruple by 2028 compared to 2023

    60% confidence
  • AI electricity consumption could account for up to 12 percent of all U.S. power by 2028

    60% confidence
  • Constraints like shortages can lead to interesting technology solutions

    60% confidence
  • Generative AI queries consumed 15 terawatt-hours in 2025 and are projected to consume 347 TWh by 2030

    60% confidence
  • Makers of AI processors, notably Nvidia and AMD, are demanding more and more memory for each of their chips, driven by needs of firms like Google, Microsoft, OpenAI, and Anthropic

    60% confidence
  • AI electricity consumption could account for up to 12 percent of all U.S. power by 2028

    60% confidence
  • AI hyperscalers' ravenous appetite for memory is causing current DRAM shortage, particularly for high bandwidth memory (HBM), which is a major constraint on the speed at which large language models run

    60% confidence
  • Data centers might steer toward hardware that sacrifices some performance for less memory, and startups might pivot toward creative redesigns that use less memory as constraints lead to interesting technology solutions

    60% confidence
  • Data centers might steer toward hardware that sacrifices some performance for less memory as adaptation to shortage

    60% confidence
  • AI hyperscalers' ravenous appetite for memory is a major constraint on the speed at which large language models run

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com